128 related articles for article (PubMed ID: 27648143)
21. Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
Jongen L; Floris G; Wildiers H; Claessens F; Richard F; Laenen A; Desmedt C; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; Neven P
Breast Cancer Res Treat; 2019 Aug; 176(3):699-708. PubMed ID: 31106385
[TBL] [Abstract][Full Text] [Related]
22. Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations.
Pistelli M; Caramanti M; Biscotti T; Santinelli A; Pagliacci A; De Lisa M; Ballatore Z; Ridolfi F; Maccaroni E; Bracci R; Berardi R; Battelli N; Cascinu S
Cancers (Basel); 2014 Jun; 6(3):1351-62. PubMed ID: 24978437
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.
Bhattarai S; Klimov S; Mittal K; Krishnamurti U; Li XB; Oprea-Ilies G; Wetherilt CS; Riaz A; Aleskandarany MA; Green AR; Ellis IO; Cantuaria G; Gupta M; Manne U; Agboola J; Baskovich B; Janssen EAM; Callagy G; Walsh EM; Mehta A; Dogra A; Shet T; Gajaria P; Traina T; Nggada HA; Omonisi A; Ahmed SA; Rakha EA; Rida P; Aneja R
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319547
[TBL] [Abstract][Full Text] [Related]
24. Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
Abd-Elazeem MA; Abd-Elazeem MA
Ann Diagn Pathol; 2015 Feb; 19(1):37-42. PubMed ID: 25456318
[TBL] [Abstract][Full Text] [Related]
25. Triple negative breast cancer: looking for the missing link between biology and treatments.
Palma G; Frasci G; Chirico A; Esposito E; Siani C; Saturnino C; Arra C; Ciliberto G; Giordano A; D'Aiuto M
Oncotarget; 2015 Sep; 6(29):26560-74. PubMed ID: 26387133
[TBL] [Abstract][Full Text] [Related]
26. Targeting the androgen receptor in triple-negative breast cancer: current perspectives.
Mina A; Yoder R; Sharma P
Onco Targets Ther; 2017; 10():4675-4685. PubMed ID: 29033586
[TBL] [Abstract][Full Text] [Related]
27. Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study.
Anand A; Singh KR; Kumar S; Husain N; Kushwaha JK; Sonkar AA
Breast Care (Basel); 2017 Jul; 12(3):160-164. PubMed ID: 28785183
[TBL] [Abstract][Full Text] [Related]
28. An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers.
Rajarajan S; Snijesh VP; Anupama CE; Nair MG; Mavatkar AD; Naidu CM; Patil S; Nimbalkar VP; Alexander A; Pillai M; Jolly MK; Sabarinathan R; Ramesh RS; Bs S; Prabhu JS
Transl Oncol; 2023 Nov; 37():101761. PubMed ID: 37603927
[TBL] [Abstract][Full Text] [Related]
29. The Androgen Receptor in Breast Cancer.
Giovannelli P; Di Donato M; Galasso G; Di Zazzo E; Bilancio A; Migliaccio A
Front Endocrinol (Lausanne); 2018; 9():492. PubMed ID: 30210453
[TBL] [Abstract][Full Text] [Related]
30. AR Signaling in Breast Cancer.
Rahim B; O'Regan R
Cancers (Basel); 2017 Feb; 9(3):. PubMed ID: 28245550
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor expression in triple negative breast carcinoma and its association with the clinicopathological parameters.
Teoh PY; Tan GC; Mahsin H; Wong YP
Malays J Pathol; 2019 Aug; 41(2):125-132. PubMed ID: 31427547
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis.
Wang C; Pan B; Zhu H; Zhou Y; Mao F; Lin Y; Xu Q; Sun Q
Oncotarget; 2016 Jul; 7(29):46482-46491. PubMed ID: 27374089
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of PIK3CA protein expression in triple negative breast cancer and its subtypes.
Elfgen C; Reeve K; Moskovszky L; Güth U; Bjelic-Radisic V; Fleisch M; Tausch C; Varga Z
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2051-2059. PubMed ID: 31270600
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype.
Gerratana L; Basile D; Buono G; De Placido S; Giuliano M; Minichillo S; Coinu A; Martorana F; De Santo I; Del Mastro L; De Laurentiis M; Puglisi F; Arpino G
Cancer Treat Rev; 2018 Jul; 68():102-110. PubMed ID: 29940524
[TBL] [Abstract][Full Text] [Related]
35. The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Michele C; Tuccari G; Adamo V
Oncotarget; 2017 Sep; 8(44):76974-76986. PubMed ID: 29100362
[TBL] [Abstract][Full Text] [Related]
36. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor and enzymes in lymph node metastasis and cancer reoccurrence in triple-negative breast cancer.
McNamara KM; Yoda T; Miki Y; Nakamura Y; Suzuki T; Nemoto N; Miyashita M; Nishimura R; Arima N; Tamaki K; Ishida T; Ohuchi N; Sasano H
Int J Biol Markers; 2015 May; 30(2):e184-9. PubMed ID: 25588857
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer.
Roseweir AK; McCall P; Scott A; Liew B; Lim Z; Mallon EA; Edwards J
Oncotarget; 2017 Jun; 8(23):37172-37185. PubMed ID: 28415597
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer.
Hu XQ; Chen WL; Ma HG; Jiang K
Oncotarget; 2017 Aug; 8(34):56364-56374. PubMed ID: 28915596
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.
Yam C; Mani SA; Moulder SL
Oncologist; 2017 Sep; 22(9):1086-1093. PubMed ID: 28559413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
